Lipid MetabolismMarch 18, 20265 min read

Everything You Need to Know About Fatty acid synthesis for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for Fatty acid synthesis. Include First Aid cross-references.

Everything You Need to Know About Fatty Acid Synthesis for Step 1

Fatty acid synthesis is a high-yield core pathway in lipid metabolism that links fed-state physiology, insulin signaling, and key cofactors (biotin, NADPH) with classic USMLE associations like citrate shuttle, acetyl-CoA carboxylase regulation, and malonyl-CoA’s inhibition of CPT-1. This post gives you a Step 1–focused, clinically anchored deep dive with First Aid-style takeaways.

Big Picture (Why You Should Care)

Fatty acid synthesis helps the body store excess calories as triacylglycerols (TAGs)—mainly in adipose—by converting acetyl-CoA → palmitate (C16:0) in the cytosol.

When it’s active (boards favorite):

  • Fed state
  • High insulin
  • High citrate (signals abundant energy)
  • Low glucagon/epinephrine

Organs that matter:

  • Liver (major site of de novo FA synthesis)
  • Adipose (more storage-focused; receives FA via VLDL and chylomicrons)

Definition & Core Concept

Fatty acid synthesis is the cytosolic production of fatty acids (primarily palmitate) from acetyl-CoA, using:

  • ATP
  • NADPH
  • Biotin (B7) as a cofactor for the rate-limiting step

Key products and uses:

  • Palmitate → can be elongated/desaturated (in ER)
  • Fatty acids → esterified into TAGs (storage) or used for membrane lipids

Where It Happens (Cellular Localization = Classic Question)

StepLocationHigh-yield note
Acetyl-CoA generated (PDH)MitochondriaAcetyl-CoA cannot cross mitochondrial membrane directly
Acetyl-CoA exported as citrateMito → cytosolCitrate shuttle transports carbons out
Fatty acid synthesisCytosolUses fatty acid synthase complex
Elongation/desaturationSmooth ERHumans cannot introduce double bonds beyond Δ9

Step-by-Step Pathway (The “Must Know” Flow)

1) Getting acetyl-CoA into the cytosol: The Citrate Shuttle

  1. In mitochondria: acetyl-CoA + OAA → citrate (TCA)
  2. Citrate moves to cytosol
  3. ATP citrate lyase cleaves citrate → acetyl-CoA + OAA

First Aid cross-reference: Citrate shuttle / ATP citrate lyase; acetyl-CoA transported as citrate.

Bonus HY link: Cytosolic OAA → malate → pyruvate generates NADPH (via malic enzyme) used for FA synthesis.

2) Rate-limiting step: Making malonyl-CoA

Acetyl-CoA carboxylase (ACC) converts:

  • acetyl-CoA → malonyl-CoA

Cofactor: Biotin (B7)
Cost: ATP
This is the rate-limiting enzyme of fatty acid synthesis.

Regulation (USMLE classic):

  • Activated by:
    • Insulin (dephosphorylation)
    • Citrate (allosteric activation; signals abundant acetyl-CoA/energy)
  • Inhibited by:
    • Glucagon/epinephrine (phosphorylation)
    • Palmitoyl-CoA (feedback inhibition)

First Aid cross-reference: Acetyl-CoA carboxylase: biotin-dependent, rate-limiting; insulin activates, glucagon inhibits.

3) Building palmitate: Fatty Acid Synthase (FAS)

Fatty acid synthase uses:

  • 1 acetyl-CoA (primer)
  • multiple malonyl-CoA units (2-carbon donors)
  • NADPH (reducing power)

End product: Palmitate (C16:0)

NADPH sources (high-yield):

  • Pentose phosphate pathway (G6PD)
  • Malic enzyme (malate → pyruvate)

First Aid cross-reference: NADPH from PPP and malic enzyme supports fatty acid synthesis.

Pathophysiology & High-Yield Associations

Malonyl-CoA links synthesis ↔ oxidation (CPT-1 inhibition)

Malonyl-CoA inhibits carnitine palmitoyltransferase I (CPT-1), the enzyme that transports long-chain fatty acids into mitochondria for β-oxidation.

Translation for test day:

  • Fed state → ↑ insulin → ↑ ACC → ↑ malonyl-CoA
  • → inhibits CPT-1 → blocks β-oxidation
  • This prevents simultaneous fat synthesis and fat breakdown.

First Aid cross-reference: CPT-1 inhibited by malonyl-CoA; carnitine shuttle regulation.

Overnutrition and insulin resistance → fatty liver (NAFLD)

In insulin resistance:

  • De novo lipogenesis may remain elevated
  • Increased hepatic TAG accumulation → nonalcoholic fatty liver disease (NAFLD)

This is more Step 2–relevant clinically, but Step 1 may test:

  • biochem mechanisms
  • labs (mild ↑ AST/ALT)
  • associations with obesity/metabolic syndrome

Clinical Presentation (What It Looks Like Clinically)

Fatty acid synthesis itself isn’t usually a single “inborn error” tested like β-oxidation defects, but its dysregulation shows up in common disease:

NAFLD / NASH (common boards tie-in)

Symptoms/signs:

  • Often asymptomatic
  • Fatigue, RUQ discomfort
  • Hepatomegaly possible

Risk factors:

  • Obesity
  • Type 2 diabetes
  • Hypertriglyceridemia
  • Metabolic syndrome

Biotin deficiency (ties to ACC)

Less common but very testable.

Causes:

  • Eating raw egg whites (avidin binds biotin)
  • Long-term antibiotics (↓ gut flora production)
  • Biotinidase deficiency (peds)

Findings:

  • Dermatitis
  • Alopecia
  • Enteritis
  • Possible neurologic symptoms (depression, lethargy)

Enzymes affected (memorize):

  • Acetyl-CoA carboxylase (FA synthesis)
  • Pyruvate carboxylase (gluconeogenesis)
  • Propionyl-CoA carboxylase (odd-chain FA/AA metabolism)
  • Methylcrotonyl-CoA carboxylase (leucine metabolism)

First Aid cross-reference: Biotin deficiency: dermatitis, alopecia, enteritis; avidin; carboxylase enzymes.

Diagnosis (Step 1 vs Step 2 Emphasis)

For pathway questions (Step 1 style)

Expect prompts like:

  • “Rate-limiting step of FA synthesis”
  • “Cofactor required”
  • “What inhibits CPT-1”
  • “Source of NADPH”
  • “Which hormone activates ACC”

For NAFLD (more Step 2)

  • Mild-moderate AST/ALT elevation (often ALT > AST early)
  • Ultrasound: bright (echogenic) liver
  • Exclusion of alcohol/viral hepatitis

Treatment (Clinical + Mechanism Links)

For NAFLD/NASH (Step 2 leaning, but helpful)

  • Weight loss, diet, exercise (first-line)
  • Control diabetes and lipids
  • Avoid hepatotoxins (alcohol, unnecessary meds)

For biotin deficiency

  • Biotin supplementation
  • Stop raw egg white consumption if relevant
  • Treat underlying causes (e.g., biotinidase deficiency)

High-Yield Rapid Review (USMLE-Style Bullets)

Absolute must-know facts

  • FA synthesis occurs in the cytosol
  • Rate-limiting enzyme: acetyl-CoA carboxylase (ACC)
  • ACC requires biotin and ATP
  • Fatty acid synthase produces palmitate (C16:0)
  • NADPH comes from PPP (G6PD) and malic enzyme
  • Malonyl-CoA inhibits CPT-1 → ↓ β-oxidation during fed state
  • Insulin activates ACC (dephosphorylation); glucagon inhibits (phosphorylation)
  • Citrate activates ACC; palmitoyl-CoA inhibits (feedback)

Easy traps to avoid

  • β-oxidation is mitochondrial, but FA synthesis is cytosolic
  • Acetyl-CoA cannot cross mitochondrial membrane directly → exported as citrate
  • Humans cannot create double bonds beyond Δ9 → linoleic/linolenic are essential fatty acids (often tested in the same lipid chapter)

Quick Self-Test (Mini USMLE Practice)

  1. What is the rate-limiting enzyme in fatty acid synthesis?
    Acetyl-CoA carboxylase (ACC)

  2. Which cofactor is required for ACC?
    Biotin (B7)

  3. What molecule directly inhibits CPT-1?
    Malonyl-CoA

  4. Name two major sources of NADPH for fatty acid synthesis.
    Pentose phosphate pathway (G6PD) and malic enzyme

  5. Which hormone state favors fatty acid synthesis?
    High insulin (fed state)

First Aid Cross-References (Where This Lives in FA)

Use these as anchors while studying lipid metabolism in First Aid for the USMLE Step 1:

  • Fatty acid synthesis overview: cytosol, palmitate, fatty acid synthase
  • Acetyl-CoA carboxylase: rate-limiting, biotin, insulin/glucagon regulation
  • Citrate shuttle & ATP citrate lyase: moving acetyl-CoA equivalents to cytosol
  • NADPH sources: PPP (G6PD) and malic enzyme
  • Carnitine shuttle regulation: CPT-1 inhibition by malonyl-CoA
  • Biotin deficiency: dermatitis, alopecia, enteritis; avidin; carboxylases
Back to all articles